Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Research Type:

Sort 1 results by:

Filter Applied. Clear All

Latest Posts

April 29, 2026 Public Comment: Lozier Institute on NIH’s Request for Information on Reducing Reliance on Human Embryonic Stem Cells in NIH-Supported Research Public Comment: Lozier Institute on NIH’s Request for Information on Reducing Reliance on Human Embryonic Stem Cells in NIH-Supported Research April 14, 2026 Drug-induced Abortion After the First Trimester Drug-induced Abortion After the First Trimester April 10, 2026 Abortion Law in America Today: Confronting Infringements on Pro-life Laws Abortion Law in America Today: Confronting Infringements on Pro-life Laws
Reset All Filters
New Abortion Trends in the United States: A First Look
Maternal & Public Health

New Abortion Trends in the United States: A First Look

To allow for a preliminary view of the current state of abortion in the U.S., the Charlotte Lozier Institute (CLI) reviewed all available state reports for 2017 and 2018. As of July 2020, 38 states had released 2018 abortion statistics. CLI’s preliminary review of 2017 state abortion reporting, published in May 2019, suggested that the long-term decline in abortions in the United States may be slowing. This preliminary review of 2018 state data indicates that the decline may have been interrupted.

A Policy and Funding Evaluation Of Human Fetal Tissue Research
Life & the Law

A Policy and Funding Evaluation Of Human Fetal Tissue Research

Here we evaluate the actions and policy changes made by the Trump administration that have been taken since his term in office and analyze the current standing of federal funds used to support fetal tissue research.  First, we give a brief overview of how federal tax dollars are used to fund medical research in the U.S.

Maternal & Public Health

Abortion Reporting: North Dakota (2019)

North Dakota’s abortion report for 2019 was published in June 2020. There were 20 fewer abortions in 2019 than in 2018.

Maternal & Public Health

Abortion Reporting: South Carolina (2019)

South Carolina 2019 abortion statistics compiled by the South Carolina Department of Health and Environmental Control show that abortions increased from the previous year but remain low compared to earlier years.

Maternal & Public Health

Abortion Reporting: Arkansas (2019)

Arkansas’ 2019 abortion report was published by the Arkansas Department of Health in June 2020. The report shows that abortions declined from 2018.

Maternal & Public Health

Abortion Reporting: Michigan (2019)

There were 27,339 abortions reported in Michigan in 2019, up two percent from the previous year. Chemical abortions jumped by 14 percent from 10,220 in 2018 to 11,609 in 2019, making up 42 percent of the total in 2019. The Charlotte Lozier Institute (CLI) estimates that Michigan’s 2019 abortion rate was 14.5 abortions per 1,000 women ages 15-44, an increase of two percent from the prior year and higher than the national rate.

Maternal & Public Health

Abortion Reporting: Nebraska (2019)

Nebraska’s 2019 abortion report was published in June 2020 by the Nebraska Department of Health and Human Services. The report shows that chemical abortions increased from 2018.

FDA’s Race to Defend Women From Dangerous Drugs
Life & the Law

FDA’s Race to Defend Women From Dangerous Drugs

Abortion advocates—seeking to exploit the COVID-19 crisis to advance unfettered access to abortion-inducing drugs—found a friend in federal court.  In mid-July, Judge Theodore D. Chuang issued a preliminary injunction prohibiting the Food and Drug Administration (FDA) from enforcing certain health and safety practices that abortion providers are required to follow when prescribing the only FDA-approved abortion drug regimen.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image